SwineCast Industry

Comparison of Intestinal Lesions

Comparison of intestinal lesions between Enterisol® Ileitis and Porcilis® Ileitis using a Lawsonia intracellularis mucosal homogenate seeder pig challenge modelComparison of intestinal lesions between Enterisol® Ileitis and Porcilis® Ileitis using a Lawsonia intracellularis mucosal homogenate seeder pig challenge model Dr. Jessica Seate, Boehringer Ingelheim Vetmedica, Inc, presents research on a comparison of intestinal lesions between Enterisol® Ileitis and Porcilis® Ileitis using a Lawsonia intracellularis mucosal homogenate seeder pig challenge model. Dr. Seate concludes with a summary that shares that IHC scores and histologic lesions (H&E) were lower for Enterisol® Ileitis group compared to the Porcilis® Ileitis and NVC groups, Enterisol® Ileitis had lowest percentage of PCR positives at necropsy, and IgG Lawsonia ELISA titers are not indicative of protective immunity [video].

Efficacy of Ingelvac PRRS® MLV

Efficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challengeEfficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challenge Dr. Reid Philips, Boehringer Ingelheim Vetmedica, Inc, shares insights on the efficacy of Ingelvac PRRS® MLV against a heterologous PRRSV 1-7-4 RFLP challenge. Key findings include: Ingelvac PRRS® MLV demonstrated significant protection against a virulent PRRSv ‘174’ challenge: 1) Significant reduction in viremia, 2) Significant reduction in lung lesions, and 3) Significant improvement in Daily Gain. Also, Ingelvac PRRS® MLV continues to demonstrate cross protection against new-emerging field strains [video].

Comparison Of Efficacy Between Two Pcv2 Vaccination Protocols

Comparison of efficacy between two PCV2 vaccination protocols under PCV2d field exposureComparison of efficacy between two PCV2 vaccination protocols under PCV2d field exposure Dr. Eduardo Fano, Boehringer Ingelheim Vetmedica, Inc, shares a research comparison of efficacy between two PCV2 vaccination protocols under PCV2d field exposure. Key finding: No efficacy differences between these 2 vaccination protocols were documented in this study under 1) PCV2d field/natural challenge, and 2) PRRSV Co infection [video].

What Does The Weather Look Like In 2017?

Weather Outlook 2017 & BeyondWeather Outlook 2017 & Beyond Dr. Elwynn Taylor, Iowa State University, provides an update on what the weather will be like through 2017. Dr. Taylor enforces the idea of assigning real values to risk and understanding what they mean. Dr. Taylor discusses some of the key areas on Earth that impact corn and soybean and what to watch for [video].

How Are The Protein and Consumer Markets Doing?

Protien and Consumer Markets OutlookProtein and Consumer Markets Outlook Dr. Steve Meyer, Vice President, Pork Analysis, EMI Analytics, provides a focused view on consumer demand and the short term futures that will impact prices and markets. Dr. Meyer also looks at proteins across the board and what planning farm management needs to consider [video].
Syndicate content